Evidence map›Paper›PMID 32526875›Full record

ReviewNutrients2020

Abscisic Acid: A Conserved Hormone in Plants and Humans and a Promising Aid to Combat Prediabetes and the Metabolic Syndrome.

Mirko Magnone, Laura Sturla, Lucrezia Guida, Sonia Spinelli, Giulia Begani, Santina Bruzzone, Chiara Fresia, Elena Zocchi

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Abscisic acid binds to anFrontiers in plant science · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Mirko MagnoneNutravis S.r.l., Via Corsica 2/19, 16128 Genova, Italy.
Laura SturlaDepartment of Experimental Medicine, University of Genova, 16132 Genova, Italy.
Lucrezia GuidaDepartment of Experimental Medicine, University of Genova, 16132 Genova, Italy.
Sonia SpinelliDepartment of Experimental Medicine, University of Genova, 16132 Genova, Italy.ORCID 0000-0001-9847-4308
Giulia BeganiDepartment of Experimental Medicine, University of Genova, 16132 Genova, Italy.
Santina BruzzoneDepartment of Experimental Medicine, University of Genova, 16132 Genova, Italy.
Chiara FresiaMolecular and Cell Biology Laboratory, Salk Institute for Biological Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037, USA.
Elena ZocchiDepartment of Experimental Medicine, University of Genova, 16132 Genova, Italy.
University of Genoa · ITSalk Institute for Biological Studies · US

Funding

Università degli Studi di Genova FRA2019
6 · The paper itself

Abstract

Abscisic acid (ABA) is a hormone with a very long evolutionary history, dating back to the earliest living organisms, of which modern (ABA-producing) cyanobacteria are likely the descendants, well before separation of the plant and animal kingdoms, with a conserved role as a signal regulating cell responses to environmental challenges. In mammals, nanomolar ABA controls the metabolic response to glucose availability by stimulating glucose uptake in skeletal muscle and adipose tissue with an insulin-independent mechanism and increasing energy expenditure in the brown and white adipose tissues. Activation by ABA of AMP-dependent kinase (AMPK), in contrast to the insulin-induced activation of AMPK-inhibiting Akt, is responsible for stimulation of GLUT4-mediated muscle glucose uptake, and for the browning effect on white adipocytes. Intake of micrograms per Kg body weight of ABA improves glucose tolerance in both normal and in borderline subjects and chronic intake of such a dose of ABA improves blood glucose, lipids and morphometric parameters (waist circumference and body mass index) in borderline subjects for prediabetes and the metabolic syndrome. This review summarizes the most recent results obtained in vivo with microgram amounts of ABA, the role of the receptor LANCL2 in the hormone's action and the significance of the endowment by mammals of two different hormones controlling the metabolic response to glucose availability. Finally, open issues in need of further investigation and perspectives for the clinical use of nutraceutical ABA are discussed.

Indexed as

Abscisic AcidAdipose TissueAnimalsBlood GlucoseDiabetes, GestationalDiabetes Mellitus, Type 2FemaleHumansInflammationInsulinLipidsMembrane ProteinsMetabolic SyndromePhosphate-Binding ProteinsPrediabetic StatePregnancyAbscisic AcidBlood GlucoseInsulinLANCL2 protein, humanLANCL2 protein, mouseLipidsMembrane ProteinsPhosphate-Binding Proteinsabscisic acidadipocyte browningAMP-activated protein kinasefood supplementinsulin resistancemetabolic syndromeprediabetestype 2 diabetes mellitus

Identifiers

PMID32526875
PMCPMC7352484
OpenAlexW3034271437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.